American International Group, Inc. Aquestive Therapeutics, Inc. Transaction History

American International Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$3.29 - $5.21 $38,101 - $60,337	-11,581 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$4.17 - $6.73 $129 - $208	31 Added 0.27%	11,581 $60,000
Q4 2020 Feb 12, 2021	SELL	$4.65 - $7.79 $1,543 - $2,586	-332 Reduced 2.79%	11,550 $62,000
Q3 2020 Nov 04, 2020	SELL	$4.12 - $9.09 $1,116 - $2,463	-271 Reduced 2.23%	11,882 $58,000
Q2 2020 Aug 12, 2020	BUY	$1.84 - $6.44 $22,361 - $78,265	12,153 New	12,153 $59,000
Q2 2019 Aug 13, 2019	SELL	$3.72 - $6.95 $26,824 - $50,116	-7,211 Closed	0 $0
Q1 2019 May 06, 2019	BUY	$5.74 - $8.05 $21,651 - $30,364	3,772 Added 109.68%	7,211 $50,000
Q4 2018 Feb 13, 2019	SELL	$6.09 - $18.0 $152 - $450	-25 Reduced 0.72%	3,439 $22,000
Q3 2018 Nov 09, 2018	BUY	$15.0 - $18.96 $51,960 - $65,677	3,464 New	3,464 $61,000

122

46.8M

517K

207K

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $245M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.